Cite
Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett’s esophagus: a traslational approach
MLA
Villanacci, V., et al. Targeted Therapy with Trastuzumab in Dysplasia and Adenocarcinoma Arising in Barrett’s Esophagus: A Traslational Approach. Jan. 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3662..e5ff65504bf3be98ffcca60dcd3717bb&authtype=sso&custid=ns315887.
APA
Villanacci, V., Rossi, E., Grisanti, S., Bassotti, G., Ferrari, V., Missale, G., Minelli, L., Cengia, P., Marini, G., & Cestari, R. (2008). Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett’s esophagus: a traslational approach.
Chicago
Villanacci, V, E Rossi, S Grisanti, G Bassotti, Vd Ferrari, Guido Missale, L Minelli, P Cengia, G Marini, and Renzo Cestari. 2008. “Targeted Therapy with Trastuzumab in Dysplasia and Adenocarcinoma Arising in Barrett’s Esophagus: A Traslational Approach,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......3662..e5ff65504bf3be98ffcca60dcd3717bb&authtype=sso&custid=ns315887.